Logo 1 Logo 2

Clinical Trial Details

Trial ID: L0287
Source ID: NCT02334488
Associated Drug: Everolimus
Title: Study Evaluating the Benefit of Two Immunosuppressive Strategies on Renal Function
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Chronic Kidney Disease
Interventions: DRUG: Everolimus|DRUG: Tacrolimus|DRUG: Mycophenolate sodium
Outcome Measures: Primary: Renal function as measured by estimated glomerular filtration rate GFR, GFR unit : mL / min / 1.73 m2, One year after inclusion |
Sponsor/Collaborators: Sponsor: Poitiers University Hospital
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 329
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2014-12-11
Completion Date: 2020-07-03
Results First Posted:
Last Update Posted: 2021-01-29
Locations: Amiens University Hospital, Amiens, 80000, France|Angers University Hospital, Angers, 49100, France|Brest University Hospital, Brest, 29200, France|Caen University Hospital, Caen, 14033, France|Clermont Ferrand University Hospital, Clermont Ferrand, 63000, France|Limoges University Hospital, Limoges, 87000, France|Georges Pompidou European Hospital, Paris, 75015, France|Necker Hospital, Paris, 75015, France|Poitiers University Hospital, Poitiers, 86000, France|Reims University Hospital, Reims, 51000, France|Rennes University Hospital, Rennes, 35000, France|Rouen University Hospital, Rouen, 76000, France|Strasbourg University Hospital, Strasbourg, 67000, France|Tours University Hospital, Tours, 37000, France
URL: https://clinicaltrials.gov/show/NCT02334488